Amwell Faces Potential NYSE American Delisting Notice
Ticker: AMWL · Form: 8-K · Filed: Apr 4, 2024 · CIK: 1393584
Sentiment: bearish
Topics: delisting, compliance, exchange-listing
Related Tickers: AMWL
TL;DR
Amwell got a notice about possibly getting kicked off NYSE American. Big trouble?
AI Summary
American Well Corp. (Amwell) filed an 8-K on April 4, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing indicates a potential issue with meeting the listing requirements for its securities on the NYSE American exchange, though specific details regarding the rule or standard not met are not provided in this excerpt.
Why It Matters
This filing signals potential financial distress or non-compliance with exchange rules, which could lead to significant stock price volatility and investor concern.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the liquidity and marketability of the company's stock, indicating severe financial or compliance issues.
Key Players & Entities
- American Well Corporation (company) — Registrant
- NYSE American (company) — Exchange where securities are listed
- 0000950170-24-041830 (other) — Accession Number for the filing
- 001-39515 (other) — Commission File Number
FAQ
What specific listing rule or standard did American Well Corporation fail to meet?
The provided excerpt of the 8-K filing does not specify which particular listing rule or standard American Well Corporation failed to satisfy, only that a notice was issued.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is April 02, 2024.
Which stock exchange is American Well Corporation potentially facing delisting from?
American Well Corporation is potentially facing delisting from the NYSE American exchange.
What is the filing date of this 8-K report?
This 8-K report was filed on April 04, 2024.
What is the principal executive office address for American Well Corporation?
The principal executive office address is 75 State Street, 26th Floor, Boston, Massachusetts 02109.
Filing Stats: 781 words · 3 min read · ~3 pages · Grade level 11 · Accepted 2024-04-04 16:28:48
Key Financial Figures
- $0.01 — hich registered Class A Common Stock, $0.01 Par Value AMWL New York Stock Excha
- $1.00 — tock (the "Common Stock") was less than $1.00 per share over a consecutive 30 trading
Filing Documents
- amwl-20240402.htm (8-K) — 42KB
- amwl-ex99_1.htm (EX-99.1) — 12KB
- 0000950170-24-041830.txt ( ) — 168KB
- amwl-20240402.xsd (EX-101.SCH) — 24KB
- amwl-20240402_htm.xml (XML) — 5KB
01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 2, 2024, American Well Corporation (the "Company") received a notice from the New York Stock Exchange (the "NYSE") that the Company was not in compliance with the continued listing minimum price criteria set forth in Section 802.01C of the NYSE's Listed Company Manual ("Section 802.01C") because the average closing price of the Company's Class A Common Stock (the "Common Stock") was less than $1.00 per share over a consecutive 30 trading-day period. The notice has no immediate impact on the listing of the Common Stock on the NYSE, subject to the Company's compliance with the NYSE's other continued listing requirements. Pursuant to Section 802.01C, the Company has a period of six months following the receipt of the notice to regain compliance with the minimum price criteria. The Company may regain compliance at any time during the six-month cure period if, on the last trading day of any calendar month during the six-month cure period, the Common Stock has a closing price of at least $1.00 per share and an average closing price of at least $1.00 per share over the 30 trading-day period ending on the last trading day of that month. The Company has already confirmed to the NYSE of its intent to regain compliance with the requirements of Section 802.01C, including by effecting a reverse stock split, subject to board approval and stockholder approval at its upcoming 2024 annual meeting. The notice does not affect the Company's business operations or its reporting obligations with the Securities and Exchange Commission.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On April 4, 2024, the Company issued a press release related to the foregoing. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference to this Item 7.01. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is not to be incorporated by reference into any filing by Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language contained in such filing, unless otherwise expressly stated in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibit is being filed herewith: 99.1 Press Release, dated April 4, 2024, issued by American Well Corporation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMERICAN WELL CORPORATION Date: April 4, 2024 By: /s/ Bradford Gay Bradford Gay Senior Vice President & General Counsel